$310 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 53 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 18.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $30,218,000 | +26.0% | 389,000 | -10.4% | 9.76% | +22.3% |
| NBIX | Buy | Neurocrine Biosciences Inc | $21,328,000 | +60.6% | 221,800 | +109.6% | 6.88% | +56.0% |
| GILD | Buy | Gilead Sciences Inc | $20,286,000 | -10.3% | 321,284 | +5.9% | 6.55% | -12.9% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $20,048,000 | +36.4% | 486,000 | +59.3% | 6.47% | +32.5% |
| BMRN | Buy | Biomarin Pharmaceutical Inc | $18,806,000 | -17.1% | 247,584 | +33.4% | 6.07% | -19.5% |
| VRTX | Vertex Pharmaceuticals Inc | $17,615,000 | -4.7% | 64,822 | 0.0% | 5.69% | -7.5% | |
| PTCT | PTC Therapuetics COM | $13,951,000 | -7.8% | 299,000 | 0.0% | 4.50% | -10.5% | |
| EXEL | Buy | Exelixis Inc | $12,853,000 | +25.0% | 526,534 | +16.4% | 4.15% | +21.4% |
| SGEN | Buy | SEATTLE GENETICS INC | $12,818,000 | +40.5% | 65,500 | +18.0% | 4.14% | +36.4% |
| BIIB | Sell | Biogen Inc | $12,349,000 | -7.3% | 43,600 | -14.8% | 3.99% | -10.0% |
| AMGN | Sell | Amgen Inc | $11,175,000 | -7.2% | 44,000 | -15.4% | 3.61% | -9.9% |
| MYOK | Myokardia INC | $8,979,000 | +40.9% | 65,859 | 0.0% | 2.90% | +36.9% | |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $8,931,000 | +186.3% | 137,400 | +205.3% | 2.88% | +178.0% |
| ALXN | Sell | Alexion Pharmaceuticals Inc | $8,601,000 | -12.4% | 75,241 | -14.7% | 2.78% | -14.9% |
| HALO | Halozyme Therapeutics Inc | $8,075,000 | +1.7% | 307,633 | 0.0% | 2.61% | -1.2% | |
| XLRN | Buy | ACCELERON PHARMA INC | $7,978,000 | +361.4% | 71,000 | +294.4% | 2.58% | +347.8% |
| INCY | Incyte Corp | $7,000,000 | -12.4% | 78,000 | 0.0% | 2.26% | -14.9% | |
| REGN | Regeneron Pharmaceuticals | $6,431,000 | -8.4% | 11,500 | 0.0% | 2.08% | -11.0% | |
| ALNY | Alnylam Pharmaceuticals Inc | $5,278,000 | -1.7% | 36,300 | 0.0% | 1.70% | -4.5% | |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $4,773,000 | – | 145,000 | +100.0% | 1.54% | – |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $4,462,000 | -11.3% | 26,900 | -38.7% | 1.44% | -13.9% |
| SRPT | Buy | Sarepta Therapeutics Inc | $4,424,000 | +26.4% | 31,500 | +46.5% | 1.43% | +22.8% |
| IMMU | Sell | IMMUNOMEDICS INC | $4,224,000 | -72.5% | 49,700 | -88.9% | 1.36% | -73.2% |
| TPTX | TURNING POINT THERAPEUTICS I | $3,050,000 | +36.4% | 35,000 | 0.0% | 0.98% | +32.6% | |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $2,969,000 | – | 152,000 | +100.0% | 0.96% | – |
| IMUX | IMMUNIC INC | $2,278,000 | +48.8% | 123,000 | 0.0% | 0.74% | +44.4% | |
| KALV | Kalvista Pharmaceuticals Inc | $2,232,000 | -0.6% | 177,433 | 0.0% | 0.72% | -3.5% | |
| ASND | Ascendis Pharma ASsponsored adr | $2,125,000 | +6.3% | 13,800 | 0.0% | 0.69% | +3.3% | |
| IONS | Ionis Pharmaceuticals Inc | $1,888,000 | -20.1% | 39,781 | 0.0% | 0.61% | -22.4% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $1,838,000 | +11.3% | 22,000 | 0.0% | 0.59% | +8.0% | |
| BPMC | Buy | Blueprint Medicines Corp | $1,808,000 | +96.9% | 19,500 | +62.5% | 0.58% | +91.5% |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $1,694,000 | – | 115,000 | +100.0% | 0.55% | – |
| STRO | SUTRO BIOPHARMA INC | $1,397,000 | +27.3% | 139,331 | 0.0% | 0.45% | +23.6% | |
| MRSN | New | MERSANA THERAPEUTICS INC | $1,340,000 | – | 72,000 | +100.0% | 0.43% | – |
| FOLD | Amicus Therapeutics Inc | $1,336,000 | -9.1% | 94,600 | 0.0% | 0.43% | -11.9% | |
| CCXI | Sell | CHEMOCENTRYX INC | $1,292,000 | -87.7% | 23,600 | -87.7% | 0.42% | -88.0% |
| ALLK | ALLAKOS INC | $1,279,000 | +11.9% | 15,700 | 0.0% | 0.41% | +8.7% | |
| ARNA | Arena Pharmaceuticals Inc | $1,234,000 | +19.0% | 16,500 | 0.0% | 0.40% | +15.4% | |
| GBT | Buy | Global Blood Therapeutics | $1,202,000 | +84.4% | 21,800 | +122.4% | 0.39% | +78.8% |
| NKTR | NEKTAR THERAPEUTICS | $1,110,000 | -26.0% | 67,000 | 0.0% | 0.36% | -28.1% | |
| EXAS | Exact Sciences Corp | $1,091,000 | +18.6% | 10,700 | 0.0% | 0.35% | +15.0% | |
| INSM | INSMED INC | $1,080,000 | +19.7% | 33,600 | 0.0% | 0.35% | +16.3% | |
| QURE | UNIQURE NV | $1,013,000 | -19.4% | 27,500 | 0.0% | 0.33% | -21.8% | |
| GWPH | GW Pharmaceuticals Plcads | $993,000 | -20.2% | 10,200 | 0.0% | 0.32% | -22.5% | |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $872,000 | -12.3% | 17,000 | 0.0% | 0.28% | -14.5% | |
| FGEN | FibroGen Inc | $810,000 | +1.4% | 19,700 | 0.0% | 0.26% | -1.9% | |
| AGIO | Agios Pharmaceuticals Inc | $752,000 | -34.0% | 21,500 | 0.0% | 0.24% | -35.9% | |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $637,000 | +10.0% | 24,800 | +7.8% | 0.21% | +7.3% |
| BLUE | Bluebird Bio Inc | $593,000 | -10.2% | 11,000 | 0.0% | 0.19% | -12.8% | |
| CYTK | New | CYTOKINETICS INC | $541,000 | – | 25,000 | +100.0% | 0.18% | – |
| ESPR | ESPERION THERAPEUTICS INC NE | $353,000 | -21.9% | 9,500 | 0.0% | 0.11% | -24.0% | |
| ZEAL | ZEALAND PHARMA A Ssponsored adr | $210,000 | +12.3% | 5,653 | 0.0% | 0.07% | +9.7% | |
| ANAB | ANAPTYSBIO INC | $148,000 | -34.8% | 10,000 | 0.0% | 0.05% | -36.0% | |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -27,000 | -100.0% | -0.32% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -23,100 | -100.0% | -0.43% | – |
| SAGE | Exit | Sage Therapeutics Inc | $0 | – | -37,600 | -100.0% | -0.52% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -46,500 | -100.0% | -0.76% | – |
| ZGNX | Exit | Zogenix Inc | $0 | – | -236,832 | -100.0% | -2.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-12-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.